afstyla powder and solvent for solution for injection 2000iuvial
csl behring pte. ltd. - lonoctocog alfa - injection, powder, lyophilized, for solution - lonoctocog alfa 2000iu/vial
afstyla powder and solvent for solution for injection 250iuvial
csl behring pte. ltd. - lonoctocog alfa - injection, powder, lyophilized, for solution - lonoctocog alfa 250iu/vial
afstyla powder and solvent for solution for injection 3000iuvial
csl behring pte. ltd. - lonoctocog alfa - injection, powder, lyophilized, for solution - lonoctocog alfa 3000iu/vial
afstyla powder and solvent for solution for injection 500iuvial
csl behring pte. ltd. - lonoctocog alfa - injection, powder, lyophilized, for solution - lonoctocog alfa 500iu/vial
haemocomplettan p powder for solution for injection or infusion 1gvial
csl behring pte. ltd. - human fibrinogen - injection, powder, lyophilized, for solution - human fibrinogen 0.900-1.300 g/vial
idelvion powder and solvent for solution for injection 1000iuvial
csl behring pte. ltd. - albutrepenonacog alfa - injection, powder, lyophilized, for solution - albutrepenonacog alfa 1000iu/vial
idelvion powder and solvent for solution for injection 2000iuvial
csl behring pte. ltd. - albutrepenonacog alfa - injection, powder, lyophilized, for solution - albutrepenonacog alfa 2000iu/vial
idelvion powder and solvent for solution for injection 250iuvial
csl behring pte. ltd. - albutrepenonacog alfa - injection, powder, lyophilized, for solution - albutrepenonacog alfa 250iu/vial
idelvion powder and solvent for solution for injection 500iuvial
csl behring pte. ltd. - albutrepenonacog alfa - injection, powder, lyophilized, for solution - albutrepenonacog alfa 500iu/vial
riastap
csl behring (nz) ltd - fibrinogen 900mg - 1300mg (human) - powder for injection - 1 g - active: fibrinogen 900mg - 1300mg (human) excipient: albumin arginine hydrochloride sodium chloride sodium citrate - treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenaemia and hypofibrinogenaemia.